Cytomegalovirus (CMV) Specific Cytotoxic T Lymphocytes (CTL) When Used for Prophylaxis Against CMV in Recipients of Allogeneic, T Cell Depleted Stem Cell Transplants

NCT00673868 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

2

Enrollment

OTHER

Sponsor class

Conditions

Cytomegalovirus Infections

Interventions

BIOLOGICAL: CMV Specific Cytotoxic T Lymphocytes

Sponsor

Milton S. Hershey Medical Center